Home » Topics » Regulatory

Regulatory
RSS

FDA approves Zoloft for social anxiety disorder

Feb. 12, 2003

No Comments

Fludara receives E.U. approval as first-line treatment for B-CLL

Feb. 11, 2003

No Comments

Positive phase III results obtained for Metformin GR in type 2 diabetes

Feb. 5, 2003

No Comments

First biologic therapy for psoriasis approved by FDA

Feb. 4, 2003

No Comments

First treatment for acute ischemic stroke cleared for use in Europe

Jan. 29, 2003

No Comments

Nabi-HB accepted for priority review for use in liver transplantation

Jan. 27, 2003

No Comments

Amgen submits sBLA for Enbrel in ankylosing spondylitis

Jan. 24, 2003

No Comments

IPD-1151T licensed to Yamanouchi for global development in cystitis and prostatitis

Jan. 23, 2003

No Comments

Lamictal approved for adjunctive use in pediatric partial seizures

Jan. 23, 2003

No Comments

Asmanex Twisthaler launched in U.K.

Jan. 23, 2003

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

FDA approves Zoloft for social anxiety disorder

Fludara receives E.U. approval as first-line treatment for B-CLL

Positive phase III results obtained for Metformin GR in type 2 diabetes

First biologic therapy for psoriasis approved by FDA

First treatment for acute ischemic stroke cleared for use in Europe

Nabi-HB accepted for priority review for use in liver transplantation

Amgen submits sBLA for Enbrel in ankylosing spondylitis

IPD-1151T licensed to Yamanouchi for global development in cystitis and prostatitis

Lamictal approved for adjunctive use in pediatric partial seizures

Asmanex Twisthaler launched in U.K.

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Regulatory RSS

Regulatory
RSS